无双THEONE完成500万天使轮融资，依托核心技术「细胞磷脂复合精粹」。36氪首发。
近日，无双THEONE宣布完成500万天使轮融资，由多家知名投资机构共同投资。此轮融资将主要用于进一步研发和推广「细胞磷脂复合精粹」技术，以实现对未来健康的更多探索。
「细胞磷脂复合精粹」技术作为一种高效的健康产品，可以促进细胞再生和修复，从而改善人体机能和预防疾病。无双THEONE将利用这一技术，打造更多针对不同人群的健康产品，为人们的未来健康提供更多保障。
此次融资将助力无双THEONE在研发、市场推广和合作伙伴拓展方面加大力度，进一步引领未来健康产业的创新潮流。
英文标题：Unrivaled THEONE raises $5 million angel round financing, technology refining future health
关键词：Unrivaled THEONE, 500万天使轮融资, technology refining, future health
新闻内容：
Unrivaled THEONE has announced the completion of its 5-million-dollar angel round financing round, led by prominent investment firms. This round of financing will support further research and development of the company’s proprietary “cell lipid complex essence” technology, enabling it to explore future health solutions.
The “cell lipid complex essence” technology, a highly efficient health product, promotes cell regeneration and repair, thereby improving human functions and preventing diseases. Unrivaled THEONE aims to leverage this technology to create various health products tailored for different populations, providing additional guarantees for future health.
This round of financing will boost the company’s efforts in R&D, market expansion, and partnership building, further driving innovation in the future health industry. With its cutting-edge technology and innovative approach, Unrivaled THEONE continues to lead the charge in this rapidly evolving field.
【来源】https://www.36kr.com/p/2556301382850951
Views: 1